The Efficiency of Chest Physiotherapy Applied in a Different Order

NCT05022082 | Completed

• 1 other identifier: BIRUNIUNIVERSITY
• Study Type: interventional
• Target: 42
• Locations: 1 country
• Sites: 1

Brief Summary

This study intends to compare the impact of chest physiotherapy applied with two different methods on physiologic parameters in children hospitalized in the intensive care unit. In the intensive care unit where the study was conducted, the patients who have a respiratory disorder and receive supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask are first administered an inhaler drug therapy placed in the physician's order. It is followed by chest physiotherapy and then oropharyngeal and nasopharyngeal aspiration. However, in practice rendered by the researcher, it is suggested that when chest physiotherapy and aspiration are administered in the first place and then followed by an inhaler drug therapy, it might have a more positive impact on the patient's physiologic parameters. For this reason, it is intended to compare the efficiency of chest physiotherapy applied in a different order.

Conditions

Respiratory Disease

Keywords

chest physiotherapy; aspiration; inhaler drugs; child; nurse

Outcome Measures

Primary Outcomes (1)

• Physiological Parameter Assessment Form Showing The Change In Heart Rate

  Chest physiotherapy applied in a different order in pediatric intensive care patients causes a difference in the patient's physiologic parameters.This form prepared by the researcher includes recording pulse rate/min in the clinic. The researcher will be assessed the pulse/min at least four times before and after the chest physiotherapy in a day. The "Patient Physiologic Parameter Assessment Form" information will be recorded before the application and 20 minutes after the application. It is known that the stress hormones epinephrine and norepinephrine half-life is 1-3 minutes, and it is believed that after a stressful invasive intervention, the release of stress hormones increases but turns back to their normal levels in 15-20 minutes. Based on this information, the pulse will be recorded in the "Patient Physiologic Parameter Assessment Form" after 20 minutes.

  This procedure will be applied to each patient for 30 minutes 4 times a day. It will be applied for at least 2 days and until the patient is discharged.

Secondary Outcomes (1)

• Physiological Parameter Assessment Form Showing The Change In SPO2%

  This procedure will be applied to each patient for 30 minutes 4 times a day. It will be applied for at least 2 days and until the patient is discharged.

Other Outcomes (3)

• Physiological Parameter Assessment Form Showing The Change In Respiration rate/min

  This procedure will be applied to each patient for 30 minutes 4 times a day. It will be applied for at least 2 days and until the patient is discharged.

• Physiological Parameter Assessment Form Showing The Change In Blood pressure (mmHg)

  This procedure will be applied to each patient for 30 minutes 4 times a day. It will be applied for at least 2 days and until the patient is discharged.

• Physiologic Parameter Assessment Form Showing The Change In Blood gas (mmHg)

  The blood gas will driven twice a day routinely.

Study Arms (2)

Chest Physiotherapy- Aspiration- Inhaler drugs group

EXPERIMENTAL

The study group (n=21) will first receive chest physiotherapy (tapotement or vibration) and aspiration, followed by inhaler drug therapy.

Other: Chest Physiotherapy- Aspiration- Inhaler drugs group

Inhaler drugs- Chest Physiotherapy- Aspiration group

OTHER

The control group (n=21) will be administered the inhaler drug routinely administered in the intensive care unit where the study is conducted and then receive chest physiotherapy (tapotement or vibration), then nasopharyngeal and oropharyngeal aspiration

Other: Chest Physiotherapy- Aspiration- Inhaler drugs group

Interventions

Chest Physiotherapy- Aspiration- Inhaler drugs group OTHER

In the intensive care unit where the study was conducted, the patients who have a respiratory disorder and receive supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask are first administered an inhaler drug therapy placed in the physician's order. It is followed by chest physiotherapy and then oropharyngeal and nasopharyngeal aspiration. However, in practice rendered by the researcher, it is suggested that when chest physiotherapy and aspiration are administered in the first place and then followed by an inhaler drug therapy, it might have a more positive impact on the patient's physiologic parameters.

Chest Physiotherapy- Aspiration- Inhaler drugs group; Inhaler drugs- Chest Physiotherapy- Aspiration group

Eligibility Criteria

• Age: 1 Month - 6 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Hospitalized patients at Cerrahpaşa Faculty of Medicine Pediatric Intensive Care Unit 1,
• Aged between 1 months-6 years,
• Having been in intensive care for at least two days,
• Concious pediatric patient,
• Receiving supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask,
• Being administered chest physiotherapy (Tapotement or Vibration),
• Being administered oropharyngeal and nasopharyngeal aspiration,
• Inhaler drug therapy included in the patient's order,
• Parents, volunteering for the study.

You may not qualify if:

• Parents not volunteering for the study,
• Patients younger than 1-month or older than 6-years old,
• Not receiving supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask
• Not being administered oropharyngeal and nasopharyngeal aspiration,
• Inhaler drug therapy is not included in the physician's order.

Sponsors & Collaborators

• Selmin Kose: lead

Study Sites (1)

Selmin Köse

Istanbul, 34010, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Respiration Disorders

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

• SEVVAL UNAL, RN

  Istanbul University-Cerrahpaşa Cerrahpaşa School of Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: CARE PROVIDER, INVESTIGATOR
• Masking Details: The researchers (are nurses) have roles of care provider and also investigator.
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: July 29, 2021
• First Posted: August 26, 2021
• Study Start: January 20, 2022
• Primary Completion: November 4, 2022
• Study Completion: November 30, 2022
• Last Updated: December 1, 2022

Record last verified: 2022-11

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)